Skip to content
PubMed This is a summary of 25 peer-reviewed journal articles Updated

What Are Prednisone Side Effects in PG and How Is It Tapered?

At a Glance

Prednisone can calm pyoderma gangrenosum but may cause infections, blood sugar and mood changes, stomach problems, and bone loss. After longer or higher-dose use, it must be reduced on an individualized schedule because stopping suddenly can cause a dangerous lack of cortisol.

Prednisone is a systemic corticosteroid that can quickly reduce the severe inflammation of pyoderma gangrenosum (PG), but it carries risks of short- and long-term side effects. While some short courses of prednisone may be stopped easily, prolonged or high-dose courses change how your body naturally produces stress hormones and require a careful “taper” (slow dose reduction) to prevent life-threatening complications [1][2].

It is important to remember that not everyone experiences every side effect, and controlling your painful ulcers is a priority. Your care team will work with you to manage these risks and decide on the safest treatment path.

Potential Side Effects and When to Seek Help

Prednisone can cause a variety of side effects. Knowing what to watch for helps you understand when to contact your doctor and when to seek emergency care.

Infection Risk

Prednisone suppresses your immune system, which helps calm your PG but makes you more vulnerable to infections [1][3]. Because steroids can hide normal signs of infection (like blunting a fever), you must be extra vigilant [1].

  • Action: Call your doctor promptly or seek emergency care if you develop fever, chills, a new cough, shortness of breath, urinary symptoms, or rapidly worsening redness, warmth, pain, or drainage around your ulcer. Do not try to self-diagnose whether your ulcer is infected or just flaring.

Blood Sugar, Blood Pressure, and Fluid Retention

Prednisone can cause high blood sugar—even in people who have never had diabetes [4]. It can also lead to high blood pressure, fluid retention, and weight gain [5]. Your doctor should regularly monitor your blood pressure and glucose levels [4].

  • Action: Call your doctor if you experience extreme thirst, frequent urination, major swelling in your legs, or unexplained breathlessness.

Mood and Sleep Changes

Steroids can significantly affect your mental health. You may experience insomnia, anxiety, depression, or hypomania (feeling unusually energized, having racing thoughts, engaging in impulsive behavior, or needing very little sleep) [6][7].

  • Action: Seek urgent medical help if you experience hallucinations (psychosis), severe agitation, unsafe behavior, or suicidal thoughts [8][7].

Stomach Problems

Prednisone increases the risk of gastrointestinal issues like heartburn or stomach ulcers [9]. The risk is highest if you are 65 or older, have a history of ulcers, or take nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen [9]. Your doctor may suggest a stomach-protecting medication if you are at high risk, but it is not automatically required for everyone [10].

  • Action: Go to the emergency room immediately if you vomit blood or have black, tarry stools, as these can be signs of severe bleeding.

Bone and Eye Health

Long-term use can lead to osteoporosis (thinning of the bones) and increase your risk of cataracts or glaucoma (raised eye pressure) [11][12]. Report any new vision changes to your doctor.

Planning for Bones and Vaccinations

  • Bone Protection: If you expect to take a daily dose of prednisone (2.5 mg or more) for three months or longer, your doctor should evaluate your risk for bone fractures [13][14]. This threshold does not mean you automatically need medication; rather, it is a prompt for assessment (like a bone density scan) [15]. Your care plan may include weight-bearing exercise, fall prevention, calcium and vitamin D supplements, and specific medications like bisphosphonates (drugs that slow bone loss) [14][15].
  • Vaccination Planning: Because prednisone weakens your immune system, plan vaccinations carefully [3]. Non-live vaccines are generally safe, though they may be less effective while you are on steroids [3]. However, live vaccines are usually avoided if you are taking high doses of steroids (such as 20 mg or more per day for at least 14 days) due to the risk of severe infection [3][16]. Never get a vaccine without discussing the timing with your prescribing doctor first.

The Danger of Stopping Suddenly: Adrenal Suppression

When you take prednisone for an extended period, your brain senses the extra steroids in your system and stops telling your adrenal glands to produce cortisol, your body’s natural stress hormone [17][1]. This is called adrenal suppression.

If you stop taking prednisone abruptly, your body will not have enough cortisol to function normally or respond to physical stress (like an illness, injury, or surgery). This can trigger an adrenal crisis—a life-threatening medical emergency [18][19].

  • Emergency Warning Signs: Go to the emergency room immediately if you experience fainting or collapse, severe dizziness, profound weakness, confusion, severe abdominal pain, persistent vomiting or diarrhea, or an inability to keep your prednisone pills down [18][19][20].
  • Safety Planning: Ask your doctor for a “sick-day plan” (stress dosing) so you know how to adjust your dose if you become severely ill or need surgery. It is also highly recommended to carry a steroid emergency card or wear a medical-alert bracelet [21].

How Prednisone Is Tapered

To safely come off prolonged prednisone, your doctor will prescribe a tapering schedule. Tapering reduces the risk of withdrawal and adrenal crisis, though it does not guarantee your PG will not return [2][22].

  • A Personalized Schedule: There is no single universal tapering schedule. Your plan depends on your prednisone dose and duration, previous steroid courses, recovery of your adrenal glands, and whether you have started a “steroid-sparing” medication to help control your PG long-term [2][23].
  • The Tapering Process: Higher doses are generally reduced more quickly, but the taper slows down significantly as you approach “physiologic doses” (the normal amount of cortisol your body makes) [2]. The final stages can take months and may require morning blood tests to check your adrenal function [24][18].
  • Withdrawal vs. Flare: As your dose decreases, you might experience fatigue, nausea, body aches, or dizziness. These can be signs of glucocorticoid withdrawal syndrome or adrenal insufficiency [25][18]. Alternatively, if your ulcers worsen, it could be a PG flare or an infection [22].
  • Never Adjust Your Own Dose: Do not try to guess what your symptoms mean. Contact your care team promptly, and never change your dose on your own.

Common questions in this guide

What side effects should I watch for while taking prednisone for pyoderma gangrenosum?
Prednisone can increase the risk of infection and may raise blood sugar or blood pressure, cause fluid retention and weight gain, and affect mood or sleep. It can also cause stomach problems and, with longer use, bone thinning, cataracts, or glaucoma. Contact your care team about concerning symptoms rather than stopping the medicine yourself.
Why is it dangerous to stop prednisone suddenly?
After a prolonged or high-dose course, prednisone can make the adrenal glands reduce their normal production of cortisol, a hormone needed during stress. Stopping suddenly can leave the body without enough cortisol and cause a life-threatening adrenal crisis. Only the prescribing clinician should decide whether and how to taper.
How long does a prednisone taper for pyoderma gangrenosum take?
There is no single taper schedule or fixed length. The plan depends on the dose and duration of treatment, previous steroid courses, adrenal recovery, and whether another medicine is controlling the pyoderma gangrenosum. Dose reductions often become slower near the body's usual cortisol level, and the final steps may take months.
What symptoms mean I need emergency help during a prednisone taper?
Seek emergency care for fainting or collapse, severe dizziness or weakness, confusion, severe abdominal pain, ongoing vomiting or diarrhea, or being unable to keep prednisone down. Fever, chills, breathing problems, rapidly worsening ulcer redness or drainage, vomiting blood, or black stools also need urgent medical attention because they may signal infection or bleeding. Severe agitation, hallucinations, unsafe behavior, or suicidal thoughts require immediate help.
How can I tell prednisone withdrawal from a PG flare or infection?
Fatigue, nausea, body aches, or dizziness during dose reduction can reflect steroid withdrawal or too little cortisol. Worsening ulcers may be a pyoderma gangrenosum flare or an infection, and prednisone can hide a fever. Contact your care team promptly instead of changing the dose yourself, because these problems can look alike.
Do I need special planning for bones and vaccines while taking prednisone?
If you may take at least 2.5 mg daily for three months or longer, ask your clinician whether you need a fracture-risk assessment and bone-protection plan. Non-live vaccines are generally safe but may work less well during steroid treatment. Live vaccines are usually avoided with high-dose prednisone, such as 20 mg or more daily for at least 14 days, so discuss timing before any vaccination.
Could another medicine reduce my need for prednisone?
A steroid-sparing medicine may help control pyoderma gangrenosum over the long term and reduce reliance on prednisone. Whether one is appropriate depends on your disease, other health conditions, and treatment history, so discuss options with your prescribing care team before changing treatment.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Do I need a taper for this specific course of prednisone, and what is our plan if my ulcers worsen or I experience withdrawal symptoms as the dose decreases?
  2. 2.What specific warning signs of an adrenal crisis or severe infection mean I need to seek emergency medical care immediately?
  3. 3.Should we establish a "sick-day plan" in case I become ill, have surgery, or cannot keep my pills down, and should I carry a steroid emergency card?
  4. 4.Do my dose and medical history mean I need a fracture risk assessment, stomach protection, or regular monitoring of my blood pressure and blood sugar?
  5. 5.Is it time to discuss a "steroid-sparing" medication to control my pyoderma gangrenosum and reduce my long-term need for prednisone?
  6. 6.Which routine vaccines are safe and appropriate for me right now, and how should we time them around my prednisone treatment?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (25)
  1. 1

    European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and therapy of glucocorticoid-induced adrenal insufficiency.

    Beuschlein F, Else T, Bancos I, et al.

    European journal of endocrinology 2024; (190(5)):G25-G51 doi:10.1093/ejendo/lvae029.

    PMID: 38714321
  2. 2

    The Glucocorticoid Taper: A Primer for the Clinicians.

    Priya G, Laway BA, Ayyagari M, et al.

    Indian journal of endocrinology and metabolism 2024; (28(4)):350-362 doi:10.4103/ijem.ijem_410_23.

    PMID: 39371659
  3. 3

    Pulmonary Infections in Patients Receiving Corticosteroids and Other Immunomodulators.

    Hartman ES, Cavallazzi R

    Seminars in respiratory and critical care medicine 2026; (47(2)):215-227 doi:10.1055/a-2767-2557.

    PMID: 41475423
  4. 4

    Continuous Glucose Monitoring of Steroid-Induced Hyperglycemia in Patients With Dermatologic Diseases.

    Kleinhans M, Albrecht LJ, Benson S, et al.

    Journal of diabetes science and technology 2024; (18(4)):904-910 doi:10.1177/19322968221147937.

    PMID: 36602041
  5. 5

    Long-term Systemic Corticosteroid Exposure: A Systematic Literature Review.

    Rice JB, White AG, Scarpati LM, et al.

    Clinical therapeutics 2017; (39(11)):2216-2229 doi:10.1016/j.clinthera.2017.09.011.

    PMID: 29055500
  6. 6

    Psychiatric Symptoms Associated with Corticosteroid Use: A Systematic Review and Meta-analysis.

    Kusudo K, Mashima Y, Yasuda H, et al.

    CNS drugs 2026; (40(8)):1101-1147 doi:10.1007/s40263-026-01298-5.

    PMID: 42365562
  7. 7

    Rate of Corticosteroid-Induced Mood Changes in Patients with Inflammatory Bowel Disease: A Prospective Study.

    Ou G, Bressler B, Galorport C, et al.

    Journal of the Canadian Association of Gastroenterology 2018; (1(3)):99-106 doi:10.1093/jcag/gwy023.

    PMID: 31294728
  8. 8

    Glucocorticoid-Induced Psychosis in Children and Adolescents: A Systematic Review.

    Fani-Molky P, Bradley J, Cooper MS

    Journal of child and adolescent psychopharmacology 2023; (33(3)):78-90 doi:10.1089/cap.2022.0077.

    PMID: 37074331
  9. 9

    Risk factors for gastrointestinal complications during glucocorticoid therapy in internal medicine inpatients: a real-world retrospective analysis.

    Liu P, Li G, Yang Q, et al.

    BMC pharmacology & toxicology 2025; (26(1)):37 doi:10.1186/s40360-025-00871-w.

    PMID: 39979942
  10. 10

    The Treatment of Giant Cell Arteritis.

    Jivraj I, Tamhankar M

    Current treatment options in neurology 2017; (19(1)):2 doi:10.1007/s11940-017-0440-y.

    PMID: 28138903
  11. 11

    Up-regulation of Ifi27l2a expression in bone marrow monocytes contributes to glucocorticoid-induced bone loss.

    Wang Z, Huang C, Liu S, et al.

    Communications biology 2025; (8(1)):1590 doi:10.1038/s42003-025-08985-x.

    PMID: 41249558
  12. 12

    Safe Use of Corticosteroids in Non-Infectious Uveitis.

    Belletti M, Izquierdo-Escamez R, Tornero C, et al.

    Journal of inflammation research 2025; (18()):14441-14455 doi:10.2147/JIR.S540821.

    PMID: 41126968
  13. 13

    Advances in treatment of glucocorticoid-induced osteoporosis.

    Hsu E, Nanes M

    Current opinion in endocrinology, diabetes, and obesity 2017; (24(6)):411-417 doi:10.1097/MED.0000000000000368.

    PMID: 28857847
  14. 14

    Glucocorticoid-induced osteoporosis: who to treat with what agent?

    Rizzoli R, Biver E

    Nature reviews. Rheumatology 2015; (11(2)):98-109 doi:10.1038/nrrheum.2014.188.

    PMID: 25385412
  15. 15

    Glucocorticoid-induced osteoporosis: 2019 concise clinical review.

    Adami G, Saag KG

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2019; (30(6)):1145-1156 doi:10.1007/s00198-019-04906-x.

    PMID: 30805679
  16. 16

    Disseminated Cutaneous Herpes Zoster in a Patient with Uncontrolled Diabetes Mellitus.

    Malkud S, Patil SM

    Journal of clinical and diagnostic research : JCDR 2015; (9(7)):WD01-2 doi:10.7860/JCDR/2015/12242.6240.

    PMID: 26393187
  17. 17

    Treatment with Synthetic Glucocorticoids and the Hypothalamus-Pituitary-Adrenal Axis.

    Paragliola RM, Papi G, Pontecorvi A, Corsello SM

    International journal of molecular sciences 2017; (18(10)) doi:10.3390/ijms18102201.

    PMID: 29053578
  18. 18

    Adrenal Insufficiency in Adults: A Review.

    Vaidya A, Findling J, Bancos I

    JAMA 2025; (334(8)):714-725 doi:10.1001/jama.2025.5485.

    PMID: 40522647
  19. 19

    Adrenal crisis: prevention and management in adult patients.

    Dineen R, Thompson CJ, Sherlock M

    Therapeutic advances in endocrinology and metabolism 2019; (10()):2042018819848218 doi:10.1177/2042018819848218.

    PMID: 31223468
  20. 20

    Extensive expertise in endocrinology. Adrenal crisis.

    Allolio B

    European journal of endocrinology 2015; (172(3)):R115-24 doi:10.1530/EJE-14-0824.

    PMID: 25288693
  21. 21

    [Glucocorticoid-induced adrenal insufficiency].

    Imamovic M, Dahlqvist P, Ragnarsson O, Einarsdottir M

    Lakartidningen 2025; (122()).

    PMID: 39935313
  22. 22

    Real-world utilization of Delphi consensus diagnostic criteria for suspected pyoderma gangrenosum.

    Ji-Xu A, Liakos W, Artounian K, et al.

    Clinical and experimental dermatology 2022; (47(10)):1873-1875 doi:10.1111/ced.15298.

    PMID: 35699684
  23. 23

    Mycophenolate mofetil as adjunctive therapy to corticosteroids for the treatment of pyoderma gangrenosum: a case series and literature review.

    Hrin ML, Bashyam AM, Huang WW, Feldman SR

    International journal of dermatology 2021; (60(12)):e486-e492 doi:10.1111/ijd.15539.

    PMID: 33739458
  24. 24

    Glucocorticoid-induced adrenal insufficiency: physiological dose tapering promotes recovery.

    Mehta R, Lazarus K, Sharma A, et al.

    Endocrine connections 2026; (15(1)).

    PMID: 41489002
  25. 25

    Potential mechanisms of the glucocorticoid withdrawal syndrome.

    Snyder CN, Frontera ED, Meng J, et al.

    European journal of endocrinology 2026; (194(4)):R67-R81 doi:10.1093/ejendo/lvag062.

    PMID: 41988948

This page is for informational purposes only and does not constitute medical advice about prednisone or pyoderma gangrenosum. Your prescribing clinician should set your taper and tell you when to seek urgent care.

Get notified when new evidence is published on Pyoderma gangrenosum.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.